Stopped earlyPhase 4MS (type not specified)NCT00151294

What it found

Stopped early

The trial ended early for another reason (see below).

This trial finished 20 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • escitalopram oxalate antidepressant

What it measured

Main measures

  • Escitalopram-treated MS patients will have greater reductions in their depressive symptom scores than patients randomized to placebo

    Mood and sleep
  • Adverse events for both groups will be similar

    Safety

Other measures (1)

  • Escitalopram-treated emotionally labile patients with MS will have a greater reduction in emotional lability scores than those randomized to placebo.

Who could take part

MS (type not specified) · 18 and over

Inclusion Criteria: * Clinical diagnosis of multiple sclerosis * Having mild to moderate depressive symptoms, with or without emotional lability * Experiencing psychological distress Exclusion Criteria: * Meeting DSM-IV diagnostic criteria for Major Depressive Disorder or another Axis 1 diagnosis * Cognitive impairment * The presence of an unstable medical illness that might preclude completion of the study -

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Emotionally labile, depressed participants with multiple sclerosis treated with escitalopram will have a greater reduction in emotional lability scores and in their psychological distress scores than those who are randomized to receive placebo.

Loading reviews and guidelines…

Related trials

History

    1. Started

      Nov 2004

    2. Finished

      Oct 2006

    Assembled by software from public sources and not checked by people. Each record links to its source. Report an error